Lactibiane Tolérance 30s

Name: Lactibiane Tolérance 30s
SKU: 7056
Availability: InStock

5 Strains · 10 Billion CFU · IBS-Diarrhea & Bacterial Vaginosis

259.13 SAR

Categories: Gut Health, Lactibiane®, Microbiome Intelligence, PiLeJe

Clinical Problem

IBS-D (diarrhea-predominant) and Bacterial Vaginosis (BV) share a common thread: microbiota dysbiosis. In IBS-D, altered gut microbiota drives increased intestinal permeability and visceral hypersensitivity. In BV, depletion of protective Lactobacillus species allows pathogenic overgrowth.

Target Patient

Adults with IBS-D (diarrhea-predominant IBS)

Women with recurrent Bacterial Vaginosis

Post-antibiotic microbiota disruption

Patients with bowel urgency and frequency

Product Benefits

IBS-D Symptom Control

5-strain formula targeted to IBS-D pathophysiology. NICE CG61 endorsed. Reduces stool frequency, urgency, and abdominal pain.

BV Microbiome Restoration

Lactobacillus strains colonise and restore the vaginal microbiome — reducing recurrent BV episodes and antibiotic dependency.

Intestinal Barrier Support

Strengthens tight junctions. Reduces intestinal permeability — the core pathological mechanism in IBS-D.

Dual Indication

Single product addressing two distinct dysbiosis-driven conditions — clinical efficiency for practitioners.

Treatment Areas

IBS-D

Bacterial Vaginosis

Post-antibiotic dysbiosis

Bowel urgency and frequency

Product Composition

5 Probiotic Strains	IBS-D and BV targeted · Lactobacillus species selected for vaginal colonisation capability
10 Billion CFU	Per Sachets · HQM® certified viability at end of shelf life
Strain Selection	NICE CG61 and WGO aligned · dual gut-vaginal axis activity
Format	Oral Sachets · 30-Sachets pack · Once daily

Clinical Results

5 Strains

IBS-D + BV Targeted

10B CFU

Per Sachets

NICE CG61

Supported

WGO

Endorsed

HQM®

Certified

Dual

Indication

Treatment Protocol

Indication

IBS-D / BV

Dual indication formula

Dosage

1 Sachets / Day

With or without food

Duration

4–8 Weeks

For IBS-D · 3 months for BV prevention

Format

Oral Sachets

30-Sachets pack

Treatment Areas

IBS-D · Bacterial Vaginosis · Post-antibiotic dysbiosis · Bowel urgency and frequency

Frequently Asked Questions

How does an oral probiotic treat vaginal BV?

The gut-vaginal axis is well established. Lactobacillus species ingested orally translocate to the vaginal environment via the perianal route. Specific strains in Lactibiane Tolérance have documented vaginal colonisation capability.

Can it be taken alongside antibiotic BV treatment?

Yes — combine with antibiotic therapy for acute BV, then continue for 4–8 weeks post-treatment to prevent recurrence. Take at least 2 hours from antibiotic dose.

Scientific References

NICE CG61 IBS management guidelines · probiotic in IBS-D · Level A evidence
Recurrent BV and probiotic Lactobacillus restoration — systematic review · BJOG
WGO probiotic and prebiotic guide 2023 · vaginal microbiome restoration evidence table

Duration

All clinical data referenced from published peer-reviewed sources. For professional use by qualified healthcare providers only. Not for patient self-diagnosis or treatment.